Last reviewed · How we verify
Biological check-up — Competitive Intelligence Brief
phase 3
General Health
Biologic
Live · refreshed every 30 min
Target snapshot
Biological check-up (Biological check-up) — Centre Hospitalier Universitaire Dijon. Biological check-up involves the examination of various bodily fluids and tissues to identify potential health issues.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Biological check-up TARGET | Biological check-up | Centre Hospitalier Universitaire Dijon | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Biological check-up CI watch — RSS
- Biological check-up CI watch — Atom
- Biological check-up CI watch — JSON
- Biological check-up alone — RSS
Cite this brief
Drug Landscape (2026). Biological check-up — Competitive Intelligence Brief. https://druglandscape.com/ci/biological-check-up. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing